FINWIRES · TerminalLIVE
FINWIRES

据RBC报道,Ocular Therapeutix公司推进与FDA就眼科药物单项试验申请的谈判。

By

-- 据加拿大皇家银行资本市场(RBC Capital Markets)周二发布的报告显示,Ocular Therapeutix (OCUL) 正朝着向美国食品药品监督管理局(FDA)提交其长效治疗湿性年龄相关性黄斑变性药物axpaxli的上市申请迈进,监管机构已开始就单项试验审批途径展开正式讨论。 RBC指出,管理层表示,目前正与FDA进行磋商,这使得公司有可能基于其成功的关键性研究提交申请,而无需等待预计将于2027年初公布结果的第二项试验。 RBC还表示,公司计划在6月17日的投资者日活动上提供更多监管和项目方面的最新进展。 Ocular仍计划在2027年通过单项试验审批策略推出axpaxli,RBC重申了其对该药物“积极的获益/风险比”的看法。 RBC维持对Ocular股票的“跑赢大盘,投机性风险”评级,目标价为30美元。

Price: $9.84, Change: $+0.13, Percent Change: +1.29%

Related Articles

Japan

US Equity Markets End Higher as Nasdaq, S&P 500 Hit Records After Reports on US-Iran Peace Deal, Upbeat AMD Results

US equity indexes ended higher on Wednesday, with the S&P 500 and the Nasdaq Composite reaching new highs as the US-Iran closed in on a peace deal and Advanced Micro Devices' (AMD) Q1 results led a rally in semiconductor stocks.* The White House is close to agreeing on a one-page memorandum of understanding to end the war with Iran and set a framework for more detailed negotiations about Tehran's nuclear ambitions, Axios reported, citing two US officials and two other sources briefed on the issue.* Employment in the US private sector grew in April, ADP data showed Wednesday, ahead of nonfarm payrolls due later in the week. Private jobs grew by 109,000, representing the fastest growth pace since January 2025, compared with 120,000 expected in a Bloomberg-compiled survey.* June West Texas Intermediate crude oil fell $7.23 to settle at $95.04 per barrel, while July Brent crude, the global benchmark, was last seen down $8.59 at $101.28.* Advanced Micro Devices shares were up more than 18%, among the top gainers on the S&P 500 and the Nasdaq, after the chipmaker overnight posted stronger-than-expected fiscal Q1 results and issued an upbeat Q2 revenue outlook.* Arista Networks (ANET) shares were down nearly 14%, among the worst S&P 500 performers, after the cloud networking company issued a Q2 revenue outlook late Tuesday slightly below market estimates.

$^DJI$^IXIC$^SPX$AMD$ANET
Australia

Snap Q1 Loss Narrows, Revenue Rises; Shares Drop After Hours

Snap (SNAP) reported a Q1 loss late Wednesday of $0.05 per diluted share, narrowing from the loss of $0.08 a year earlier.Analysts polled by FactSet expected a loss of $0.07.Revenue in the three months ended March 31 rose to $1.53 billion from $1.36 billion a year earlier.Analysts surveyed by FactSet expected $1.53 billion.Snap shares fell 3.8% in after-hours trading.

$SNAP
Mining & Metals

Earnings Flash (LNR.TO) Linamar Posts Q1 Adjusted EPS $3.28 per Share, vs. FactSet Est of $2.81

$LNR.TO